How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across sectors and industries as well.
FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.
What if you'd invested in Tenet Healthcare (THC) ten years ago? It may not have been easy to hold on to THC for all that time, but if you did, how much would your investment be worth today?
Tenet Healthcare's Business In-Depth
With that in mind, let's take a look at Tenet Healthcare's main business drivers.
Founded in 1967 and headquartered in Dallas, TX, Tenet Healthcare Corp., is an investor-owned health care services company, which owns and operates general hospitals and related health care facilities for urban and rural communities in numerous states, and has offices in California and Florida. The company has investments in other health care companies and is one of the largest investor-owned health care delivery systems in the United States.
Tenet Healthcare and its subsidiaries provide healthcare services primarily through general hospitals and related healthcare facilities. Its hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies; intensive care, critical and coronary care units; physical therapy along with orthopedic, oncology, and outpatient services. The related health care facilities include rehabilitation hospitals, specialty hospitals and long-term care facilities.
As of Dec 31, 2025, the company operated an expansive care network that included 50 hospitals and other healthcare facilities, including ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments and micro-hospitals through its units, partnerships and joint ventures. Effective fourth-quarter 2023, the company combined its Conifer segment with the Hospital segment and now has two reporting segments: Hospital Operations and Services and Ambulatory Care.
Hospital Segment (75.7% of total segment revenues in 2025): It includes 50 hospitals catering to primarily urban and suburban communities in nine states. The unit also provides a number of services primarily to healthcare providers to assist them in generating sustainable improvements in their operating margins, while also managing patient, physician and employee satisfaction.
Ambulatory Care (24.3%): The company's Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities.
Bottom Line
Putting together a successful investment portfolio takes a combination of research, patience, and a little bit of risk. For Tenet Healthcare, if you bought shares a decade ago, you're likely feeling really good about your investment today.
According to our calculations, a $1000 investment made in August 2016 would be worth $10,130.81, or a gain of 913.08%, as of August 12, 2026, and this return excludes dividends but includes price increases.
Compare this to the S&P 500's rally of 253.57% and gold's return of 211.89% over the same time frame.
Analysts are forecasting more upside for THC too.
Tenet Healthcare is benefiting from higher-acuity services, strong commercial revenues, and the continued expansion of its ambulatory care platform, USPI. Growth in specialty services and ambulatory surgery centers, supported by acquisitions, de novo facility additions, and payer partnerships, continues to strengthen the company's long-term growth prospects. Management raised its 2026 adjusted EPS guidance to $20.30-$21.69 and expects hospital segment net operating revenues of $16.4-$16.8 billion, while planning to invest more than $300 million in USPI acquisitions this year. Shares of the company have outperformed its industry over the past year. However, persistent labor and supply cost inflation, unfavorable payer mix, and the stock's premium valuation remain key concerns. As such, we have a Neutral recommendation on the stock.
Shares have gained 41.24% over the past four weeks and there have been 6 higher earnings estimate revisions for fiscal 2026 compared to none lower. The consensus estimate has moved up as well.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Â

(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.